Good things ahead imo in Q3 regarding the production of proteins from algae under partnership with the major Canadian oilsands producer and Fortune 500 company: "...with a commercial supply contract potentially being entered into by years end" Aug 22, 2022 https://pondtech.com/media-releases...ch-consultant-to-accelerate-project-pipeline/ Since the beginning of 2022, Pond has been making weekly deliveries of recombinant proteins to the project consortium for testing and significant milestones are expected to be achieved in Q3 2022. May 10, 2022 https://thedeepdive.ca/pond-technol...ion-of-proteins-from-algae-under-partnership/ With the project to consist of compensation of up to $1.0 million for the Pond, the company to date has reportedly collected $230,000 in revenue from the program. The company also expects to receive a further $850,000 for its efforts via the form of milestone payments, with a commercial supply contract potentially being entered into by years end.
Very interesting read on the huge potential of Pond. The upcoming Q4 will be very interesting for sure as Pond's pilot plant is anticipated to begin operating at British Sugar’s Wissington site. Great times ahead imo. Zacks Small-Cap Research September 15, 2022 Current Price (9/14/22) US$0.10 Valuation US$0.65 CONCLUSION We believe that Pond Technologies is becoming well-positioned for winning additional contracts and can execute well on its Livalta (AB Agri) relationship. Animal feed and methane reduction remain are favorite growth catalysts for new contracts and project wins, in our view. We expect Pond to benefit from growing awareness of and potential interest in its technology as environmental issues increasingly move into the forefront for regulators, consumers and investors. https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_09152022_PNDHF_Marin.pdf
Pond Technologies Announces Closing of First Tranche of Non-Brokered Private Placement Including Insider Participation Sep 28, 2022 https://www.newswire.ca/news-releas...ncluding-insider-participation-861147580.html MARKHAM, ON, Sept. 28, 2022 /CNW/ - Further to its press release dated September 6, 2022, Pond Technologies Holdings Inc. ("Pond") ( TSXV: POND) (OTCQB: PNDHF) (FSE: 400), an ESG company addressing global sustainability challenges of wellness and climate change, announces the closing yesterday of the first tranche of its non-brokered private placement ("Private Placement") in the amount of 2,006,667 common shares of Pond ("Common Shares") at a purchase price of $0.15 per Common Share for aggregate gross proceeds of $301,000. The Common Shares issued pursuant to the first tranche are subject to a statutory hold period expiring January 28, 2022.
Pond Technologies CEO Grant Smith Wins Canada’s 2023 Clean50 Award Thursday, October 6, 2022 https://www.accesswire.com/719350/Pond-Technologies-CEO-Grant-Smith-Wins-Canadas-2023-Clean50-Award Mr. Smith was recognized in the Clean50 Clean Technology category for Pond's work in developing and commercializing its patented algae growth technology, which reduces carbon and creates sustainable biproducts. The company has developed and advanced ground-breaking technology that turns 2 tonnes of CO2 to grow 1 tonne of different kinds of valuable algae that in turn can be used in different and helpful ways. In an agreement dated September 7, 2021, Livalta (an AB AGRI Company) and Pond agreed to an exclusive global partnership to grow algae-based animal feed from CO2 emissions. The demonstration system will be used to grow algae strains for animal feed trials and the development of commercial animal feeds which will be sold by AB Agri. The Company is currently focused on completing this demonstration facility as well as progressing through its commercialization roadmap across a myriad of industries. "I am extremely honoured to have been recognized by the Clean50 program in the category of clean technology, and I sincerely want to thank the entire team at Pond for their dedication in transitioning our Company from a research and development focus to commercialization of our robust technology globally.," said Grant Smith, CEO.
Pond's business relationship with multi-billion dollar company British Sugar/AB Agri is imo worth much more than the current low market cap. According to the AB Agri website plans already exist for a commercial-sized plant at producing 20,000 tons of spirulina from CO2 emissions. https://www.abagri.com/worlds-first-scalable-production-of-algae-from-carbon-emissions "Plans are in place for Pond to install Livalta’s first pilot plant at British Sugar’s Wissington site in Norfolk in 2022. This will be followed by a commercial-sized plant at the same site producing 20,000 tons of spirulina from CO2 emissions, with the prospect of additional collaborations in the future to develop further production sites."
British Sugar got the permission for Pond's pilot plant from local authorities. Lets see where the share price will be at the end of Q4 once the CO2 to algae plant is up and running... Proposal: Erection of steel frame clad building housing pilot plant for the production of Spirulina powder Address:British Sugar PLC Wissington Sugar Factory College Road Wissington Decision: Application Permitted Decision Issued Date: 19 Oct 2022 https://online.west-norfolk.gov.uk/...ils.do?activeTab=summary&keyVal=RFXL2YIV0HX00
Great news today in my opinion. This is a major step for Pond's biotech division. According to the deep dive article from May 2022 there is the chance of "a commercial supply contract potentially being entered into by years end." The current low share price is a steal imo... Pond Announces Milestone Payment from Fortune 500 Oil & Gas Major and Provides Update on Biotech Division October 20, 2022 https://www.accesswire.com/721197/P...Major-and-Provides-Update-on-Biotech-Division "The company also expects to receive a further $850,000 for its efforts via the form of milestone payments, with a commercial supply contract potentially being entered into by years end." https://thedeepdive.ca/pond-technol...ion-of-proteins-from-algae-under-partnership/
The remaining two months of Q4 will be very exciting. Lots of possible upcoming catalysts for the share price imo... Pond's CO2 to algae pilot Livalta (AB Agri) plant is expected to begin operating in 4Q22. AB Agri is a subsidary of the 10 Billion market cap company Associated British Foods. (also see press release May 5, 2022) Pond and SEM to initially focus on Scotland-based projects with the goal to abate 10,000 tonnes of CO2 from an identified waste to energy plant using stack gas. The project is expected to commence Q4 2022 with the project scope and revenue opportunity expected to be disclosed in more detail prior to the launch date. (also see press release June 16, 2022) Results of the ongoing study regarding the announced Engagement with BioCarbN in Collaboration with Livalta/AB Agri and a Second Major Agriculture Business to Identify Methane Reducing Algae Feed Solutions in Cattle. (also see press release April 28, 2022)
Pond Technologies Announces Extension to Non-Brokered Private Placement October 25, 2022 https://www.benzinga.com/pressrelea...s-extension-to-non-brokered-private-placement
Pond's technology uses CO2 waste streams and turns it into a valuable algae product. Once the pilot plant is up and running at the British Sugar site in Q4 and the technology further validated every company with similar waste streams will want Pond's technology to reduce their costs by turning their waste into money. A no-brainer. The upside potential is imo obviously very huge in particlar considering the current low market cap. Great times ahead
Pond Technologies Announces Closing of Non-Brokered Private Placement at Premium to Market Price and Initiation of New Non-Brokered Private Placement at the Market Price Nov 01, 2022, 16:21 ET https://www.newswire.ca/news-releas...-placement-at-the-market-price-826739727.html
A Profitable Solution To The Emissions Problem? — With Grant Smith November 14, 2022 https://thedeepdive.ca/a-profitable-solution-to-the-emissions-problem-with-grant-smith/ Returning to The Daily Dive today is Grant Smith, CEO of Pond Technologies (TSXV: POND). Grant joins us to provide his outlook on the carbon trading market scheme presented by John Kerry at the COP27, and his read on the global algae protein market which is estimated to reach $1.2 billion by 2027. He also shares with us the latest on Pond Naturals, the retail product Regenurex, and the proceeds of the recent non-brokered private placement. 00:00 Introduction 00:33 His read on carbon market initiatives, particularly Kerry’s carbon-trading scheme 02:34 Global algae proteins market growth drivers 04:28 Pond Naturals — Pond Tech’s sales arm for new algae products 05:42 Proceeds of non-brokered private placement with insider participation 07:35 Regenurex algae oil 08:44 Catalysts investors can look forward to
Pond Technologies Holdings Inc. Announces Filing of 2022 Third Quarter Unaudited Interim Condensed Financial Statements, MD&A and Provides Business Update Nov 30, 2022 https://pondtech.com/media-releases...-statements-mda-and-provides-business-update/ ... Grant Smith, President and CEO of Pond, said: “Our pipeline is full as we continue to see significant demand around the world to deploy our patent protected technology into a variety of industries. In order to capture this demand, our short-term focus consists of two major initiatives. Firstly, we are scaling up our North American demonstration facility at St. Mary’s Cement in order to move prospects through our sales channel with the goal of capturing additional license revenue with prospects in our opportunities pipeline. Furthermore, we are focused and working towards securing longer term commercialization funding as we scale the business and progress on our commercial roadmap. We are making progress on both these initiatives and look forward to updating shareholders when appropriate. I also want to take this opportunity to reiterate the fact our management team and Board of Directors continue to show strong support for the future of Pond with members participating for over $550,000 into our recent private placements. We remain dedicated to enhancing shareholder value over the long term and we look forward to keeping investors apprised of those details as we move through 2023.”
Great news Pond Announces that AB Agri has Begun to Grow Algae Following the Delivery of a Pond Algae Lab https://finance.yahoo.com/news/pond-announces-ab-agri-begun-130000782.html Pond Technologies Holdings Inc. Wed, December 14, 2022 MARKHAM, ON / ACCESSWIRE / December 14, 2022 / Pond Technologies Holdings Inc. ("Pond") (TSX.V POND)(OTCQB PNDHF)(FSE:4O0), an ESG company addressing global sustainability challenges of wellness and climate change, is providing an update on its agreement with Livalta, an AB Agri company, a subsidiary of Associated British Foods (LSE:ABF). Pond is pleased to report that the installation of an algae lab, along with a number of Pond designed algae bioreactors, has been successfully installed on site at AB Agri's British Sugar plant in Wissington, UK. Pond built a system of smaller 60 L bioreactors and controls at its Canadian headquarters in Markham, Ontario, and has delivered, installed, and commissioned the system at the AB Agri Wissington location. Pond worked with AB Agri to specify the equipment needed to set up the lab which is an important step to support the 1,500 L and 10,000 L pilot bioreactors in Wissington in 2023. The initial algae grown in this lab will be used in the bioreactor scale up process. Valerie Schuster, Managing Director of Livalta (a division of AB Agri) said: "This is our first step towards piloting Pond's technology to grow algae using CO2 emissions as feedstock - or, as we would put it, take a problem (CO2 emissions) out of the air and convert it into high value protein. There is still some way to go, but we have made a start with a great team effort between Livalta, AB Agri, British Sugar and Pond Technologies." Grant Smith, President & CEO at Pond said: "Installing the lab and initial seed train is the first stage in any algal project because doing so permits larger commercial scale photobioreactors. We are excited to report that algae growth has begun, and we anticipate that larger bioreactors will go online in 2023."
The pipeline of opportunities is very promising. I expect a major increase of the share price in 2023... Pond-Corporate-Presentation-Winter-2022 https://pondtech.com/wp-content/uploads/2022/12/Pond-Corporate-Presentation-Winter-2022-.pdf
Newly Installed Lab Producing Algae - Key Milestone Towards Commercialization December 22, 2022 Zacks Small-Cap Research https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_12220222_PNDHF_Marin.pdf
Pond's Regenurex Astaxanthin algae product has a rating of 4.3 out of 5 stars at amazon. The number of ratings is 120 up to now. Very promising imo. https://www.amazon.ca/Regenurex-Astaxanthin-4mg-Pills-Inflammation/dp/B01CO58GSQ About this item ASTAXANTHIN is a potent antioxidant that helps protect cells against the oxidative damage caused by free radicals. The antioxidant properties of astaxanthin support many facets of human health. WHY REGENUREX? We farm the algae and we extract the astaxanthin gently from whole algae in a GMP facility. The algae never dehydrated and no use of harsh chemicals. As a result, Regenurex has NO FISHY SMELL OR TASTE. GROWN IN CANADA: Our farm in Agassiz, British Columbia, is Canada's only producer of astaxanthin from algae. NPN 80060233
